Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

CytomX Therapeutics, Inc. CTMX

Full chart Compare
Set alert

Price alert · CTMX

All alert types
2.35 USD +0.17 (+7.80%)

At closeNov 4, 2026, 5:03 PM EST

2.35 0.00 0.00%

After hours · Nov 4, 5:03 PM ET

2.18 Day range 2.36
2.14 52-week range 8.21
YTD
-44.84%
1 year
-42.54%

Financial health

Altman Z-Score

1.25 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 3

Valuation

P/E -28.4×
FY 2016: -6.7×FY 2017: -18.2×FY 2018: -7.4×FY 2019: -3.7×FY 2020: -9.2×FY 2021: -3.4×FY 2022: -1.1×FY 2023: -201×FY 2024: 2.7×FY 2025: -28.4×
FY 2016 5y median -3.4× FY 2025
P/S 7.7×
FY 2016: 26.5×FY 2017: 11.0×FY 2018: 10.6×FY 2019: 6.6×FY 2020: 4.4×FY 2021: 7.4×FY 2022: 2.0×FY 2023: 1.1×FY 2024: 0.6×FY 2025: 7.7×
FY 2016 5y median 2.0× FY 2025
P/B 5.9×
FY 2016: 5.1×FY 2017: 11.2×FY 2018: 4.8×FY 2019: 7.4×FY 2020: -38.9×FY 2021: -605×FY 2022: -1.2×FY 2023: -2.4×FY 2024: -191×FY 2025: 5.9×
FY 2016 5y median -2.4× FY 2025
P/FCF -7.8×
FY 2016: -94.6×FY 2017: 4.6×FY 2018: -7.9×FY 2019: -2.6×FY 2020: 102×FY 2021: -2.3×FY 2022: -0.9×FY 2023: -2.0×FY 2024: -1.0×FY 2025: -7.8×
FY 2016 5y median -2.0× FY 2025
EV/EBITDA -36.8×
FY 2016: -5.1×FY 2017: -14.5×FY 2018: -5.0×FY 2019: -2.2×FY 2020: -1.7×FY 2021: -0.8×FY 2022: 0.7×FY 2023: 20.2×FY 2024: 1.7×FY 2025: -36.8×
FY 2016 5y median 0.7× FY 2025
EV/Sales 7.6×
FY 2016: 19.5×FY 2017: 8.5×FY 2018: 6.4×FY 2019: 3.8×FY 2020: 2.0×FY 2021: 2.5×FY 2022: -1.3×FY 2023: 1.1×FY 2024: 0.4×FY 2025: 7.6×
FY 2016 5y median 1.1× FY 2025
FCF Yield -12.9%
FY 2016: -1.1%FY 2017: 21.5%FY 2018: -12.6%FY 2019: -38.2%FY 2020: 1.0%FY 2021: -43.4%FY 2022: -107.0%FY 2023: -49.7%FY 2024: -99.5%FY 2025: -12.9%
FY 2016 5y median -49.7% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -29.3%
FY 2016: -396.1%FY 2017: -64.6%FY 2018: -130.9%FY 2019: -192.9%FY 2020: -117.7%FY 2021: -311.0%FY 2022: -190.6%FY 2023: -6.4%FY 2024: 18.1%FY 2025: -29.3%
FY 2016 5y median -29.3% FY 2025
Net Margin -22.8%
FY 2016: -391.5%FY 2017: -60.2%FY 2018: -142.2%FY 2019: -177.8%FY 2020: -94.7%FY 2021: -310.5%FY 2022: -186.8%FY 2023: -0.6%FY 2024: 23.1%FY 2025: -22.8%
FY 2016 5y median -22.8% FY 2025
ROE -17.5%
FY 2016: -75.1%FY 2017: -61.7%FY 2018: -64.6%FY 2019: -200.0%FY 2020: 833.8%FY 2021: 25244.0%FY 2022: 115.8%FY 2023: 1.2%FY 2024: -6988.8%FY 2025: -17.5%
FY 2016 5y median 1.2% FY 2025
ROIC -20.5%
FY 2016: -36.5%FY 2017: -13.6%FY 2018: -21.7%FY 2019: -42.7%FY 2020: -27.4%FY 2021: -43.8%FY 2022: -90.2%FY 2023: 2.2%FY 2024: 62.2%FY 2025: -20.5%
FY 2016 5y median -20.5% FY 2025
ROA -11.5%
FY 2016: -29.6%FY 2017: -10.8%FY 2018: -18.5%FY 2019: -30.0%FY 2020: -18.1%FY 2021: -34.1%FY 2022: -38.1%FY 2023: -0.3%FY 2024: 26.4%FY 2025: -11.5%
FY 2016 5y median -11.5% FY 2025

Growth (YoY)

Revenue -44.8%
FY 2016: 95.1%FY 2017: 376.1%FY 2018: -16.9%FY 2019: -3.4%FY 2020: 19.0%FY 2021: -45.5%FY 2022: 42.5%FY 2023: 90.4%FY 2024: 36.4%FY 2025: -44.8%
FY 2016 FY 2025
Operating Income -189.5%
FY 2016: -79.5%FY 2017: 22.4%FY 2018: -68.3%FY 2019: -42.4%FY 2020: 27.4%FY 2021: -44.1%FY 2022: 12.7%FY 2023: 93.6%FY 2024: 485.5%FY 2025: -189.5%
FY 2016 FY 2025
EPS (diluted) -139.5%
FY 2016: -63.0%FY 2017: 28.8%FY 2018: -75.0%FY 2019: -11.3%FY 2020: 68.6%FY 2021: -77.5%FY 2022: -17.5%FY 2023: 99.5%FY 2024: 5035.1%FY 2025: -139.5%
FY 2016 FY 2025
Free Cash Flow 12.4%
FY 2016: 85.5%FY 2017: 4111.7%FY 2018: -147.0%FY 2019: -81.5%FY 2020: 102.0%FY 2021: -4189.5%FY 2022: 6.7%FY 2023: 49.5%FY 2024: -52.2%FY 2025: 12.4%
FY 2016 FY 2025

Financial Health

Current Ratio 3.1×
FY 2016: 5.3×FY 2017: 6.4×FY 2018: 4.5×FY 2019: 3.5×FY 2020: 4.8×FY 2021: 4.0×FY 2022: 1.6×FY 2023: 1.2×FY 2024: 1.3×FY 2025: 3.1×
FY 2016 5y median 1.6× FY 2025
Quick Ratio 3.1×
FY 2016: 5.3×FY 2017: 6.4×FY 2018: 4.5×FY 2019: 3.5×FY 2020: 4.8×FY 2021: 4.0×FY 2022: 1.6×FY 2023: 1.2×FY 2024: 1.3×FY 2025: 3.1×
FY 2016 5y median 1.6× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.5×FY 2020: -3.2×FY 2021: -47.2×FY 2022: -0.2×FY 2023: -0.3×FY 2024: -20.6×FY 2025: 0.0×
FY 2016 5y median -0.3× FY 2025
Net Debt / EBITDA 0.5×
FY 2016: 1.8×FY 2017: 4.2×FY 2018: 3.3×FY 2019: 1.6×FY 2020: 2.1×FY 2021: 1.6×FY 2022: 1.8×FY 2023: -0.6×FY 2024: -0.8×FY 2025: 0.5×
FY 2016 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2016: -35.3×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31